Cardiomyopathy Completed Phase 4 Trials for Ranolazine (DB00243)

Also known as: Cardiomyopathies / Cardiomyopathy, unspecified / Myocardial degeneration / Myocardial disease (disorder) / Cardiomyopathy NOS / Cardiomyopathy (disorder) / Myocardiodystrophy

IndicationStatusPhase
DBCOND0007414 (Cardiomyopathy)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01345188
Ranolazine in Ischemic CardiomyopathyTreatment